scispace - formally typeset
C

Csilla Sipeky

Researcher at University of Turku

Publications -  63
Citations -  2190

Csilla Sipeky is an academic researcher from University of Turku. The author has contributed to research in topics: Population & Prostate cancer. The author has an hindex of 21, co-authored 62 publications receiving 1554 citations. Previous affiliations of Csilla Sipeky include University of Pécs & UCB.

Papers
More filters
Journal ArticleDOI

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Fredrick R. Schumacher, +207 more
- 11 Jun 2018 - 
TL;DR: A large meta-analysis combining genome-wide and custom high-density genotyping array data identifies 63 new susceptibility loci for prostate cancer, enhancing fine-mapping efforts and providing insights into the underlying biology of PrCa1.
Journal ArticleDOI

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

David V. Conti, +254 more
- 04 Jan 2021 - 
TL;DR: This paper conducted a meta-analysis of prostate cancer genome-wide association studies (107,247 cases and 127,006 controls) and identified 86 new genetic risk variants independently associated with prostate cancer risk, bringing the total to 269 known risk variants.
Journal ArticleDOI

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

Tyler M. Seibert, +71 more
- 10 Jan 2018 - 
TL;DR: Polygenic hazard scores can be used for personalised genetic risk estimates that can predict for age at onset of aggressive PCa in men participating in international PRACTICAL consortium.
Journal ArticleDOI

Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis

TL;DR: There is direct evidence that some allelic variants or haplogroups of IL-23R represent independent risk factors for rheumatoid arthritis as well as Crohn’s disease, but not for scleroderma.